Skip to main content
. 2016 Jun 2;6(6):e010981. doi: 10.1136/bmjopen-2015-010981

FigureĀ 5.

FigureĀ 5

The part-worth utilities of the levels for each attribute (with 95% confidence limits), representing the relative influence of each on the choice of undergoing chemotherapy for early-stage breast cancer in the sample of n=1004 women from the general population. GEP, gene expression profiling; SE, side effects; MD, cancer treatment doctor.